Y043-2529 Screening compound: (2S)-N-[2-(6-bromo-1H-indol-1-yl)ethyl]-2-phenyl-2-(1H-1,2,3,4-tetraazol-1-yl)ethanamide

Y043-2529 Screening compound: (2S)-N-[2-(6-bromo-1H-indol-1-yl)ethyl]-2-phenyl-2-(1H-1,2,3,4-tetraazol-1-yl)ethanamide
Y043-2529 Screening compound: (2S)-N-[2-(6-bromo-1H-indol-1-yl)ethyl]-2-phenyl-2-(1H-1,2,3,4-tetraazol-1-yl)ethanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y043-2529
(2S)-N-[2-(6-bromo-1H-indol-1-yl)ethyl]-2-phenyl-2-(1H-1,2,3,4-tetraazol-1-yl)ethanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y043-2529

Molecular Formula

C19H17BrN6O (C19 H17 BrN6 O)

Compound Name

(2S)-N-[2-(6-bromo-1H-indol-1-yl)ethyl]-2-phenyl-2-(1H-1,2,3,4-tetraazol-1-yl)ethanamide

IUPAC name

(2S)-N-[2-(6-bromo-1H-indol-1-yl)ethyl]-2-phenyl-2-(1H-1234-tetrazol-1-yl)acetamide

SMILES

O=C(C(c1ccccc1)n1nnnc1)NCCn(cc1)c2c1ccc(Br)c2

InChI

InChI=1S/C19H17BrN6O/c20-16-7-6-14-8-10-25(17(14)12-16)11-9-21-19(27)18(26-13-22-23-24-26)15-4-2-1-3-5-15/h1-8,10,12-13,18H,9,11H2,(H,21,27)/t18-/m1/s1

InChI Key

YHPDFOUYXHRELC-GOSISDBHSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

425.29

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.428

Distribution Coefficient, logD

3.428

Water Solubility, LogSw

-3.51

Polar Surface Area

65.920

Acid Dissociation Constant (pKa)

12.89

Base Dissociation Constant (pKb)

0.57

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

15.79

Y043-2529 in Drug Discovery

Included in Screening Libraries

RAR (Nuclear receptors) Ligands Library (6524 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Respiratory tract
  • Eye
  • Male
  • Female
  • Hemic and lymphatic
  • Congenital
  • Skin
  • Endocrine
  • Immune system
Targets:
  • Nuclear receptors
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with Y043-2529 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y043-2529?
Check Price and Availability of Y043-2529, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y043-2529 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y043-2529
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y043-2529
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y043-2529 available by request